Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

2 out of 5 AFib patients develop heart failure later in life
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.
Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
CT procedure shown to reduce need for invasive cardiac testing
In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.

Video of David Hur discussing how to overcome technical challenges in cardiac CT, which he presented on in sessions at SCCT 2023.

Overcoming technical challenges in cardiac CT

David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.

October 17, 2023

A late-breaking science presentation at the annual TCT interventional cardiology meeting.

Late-breaking clinical trials at TCT 2023

Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting Oct. 23-26, 2023, in San Francisco.

October 17, 2023

ACC President Hadley Wilson, MD, explained the impact of 4 key ESC 2023 IVUS and OCT intravascular imaging trials and wht thaey will l;ikely influence PCI guidelines. #ESC ESC23 #ESC2023 #ACC

Intravascular imaging for PCI gets a big boost from recent studies

ACC President Hadley Wilson, MD, explains the big impact four late-breaking studies on intravascular imaging may have on revising PCI guidelines.

October 16, 2023

Technology that creates interactive holograms of the heart cleared by FDA

SentiAR's CommandEP interface facilitates 3D models of the heart, made possible through augmented reality.

October 16, 2023

Multidisciplinary quality improvement initiative significantly improves on-time starts for cardiac MRI

Such delays can result in longer patient fasts, extended wait times, and poor synchronization of anesthesia induction, researchers detailed in JACR.

October 16, 2023

Robert Hendel, MD, Tulane University and former ASNC president, explains the pressing business aspects of nuclear cardiology and why ASNC included business management sessions at its 2023 annual meeting. #ASNC #ASNC23 #ASNC2023

Business considerations in the modern nuclear cardiology practice

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview.

October 13, 2023

Newsweek ranked the 50 best heart hospitals in the world

One-stop cardiology clinic opens, offering same-day CVD diagnoses

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses.

October 12, 2023

High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns.

October 12, 2023

Cardiac Imaging

2 out of 5 AFib patients develop heart failure later in life

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation

Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

CT procedure shown to reduce need for invasive cardiac testing